M2Gen names new CEO
M2Gen, a health informatics solutions company in Tampa, named Helge Bastian as president and CEO. Bastian succeeds M2Gen Executive Chair Dr. William S. Dalton, who has served as interim CEO since September 2018. Bastian joins M2Gen from Thermo Fisher Scientific, where he led the sample preparation and synthetic biology businesses as vice president and general manager since 2014. Bastian has "a proven track record of building profitable and sustainable businesses in the life sciences and healthcare sectors," Dalton said in a news release. M2Gen was spun out by Moffitt Cancer Center and received a $75 million investment from Hearst in 2017 to accelerate the discovery of cancer therapies and improve care for patients nationwide.